View in EDS

Immunogenicity and efficacy of VLA2001 vaccine against SARS-CoV-2 infection in male cynomolgus macaques.

Saved in:
Bibliographic Details
Title: Immunogenicity and efficacy of VLA2001 vaccine against SARS-CoV-2 infection in male cynomolgus macaques.
Authors: Galhaut M; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Lundberg U; VALNEVA Austria GmbH, Vienna, Austria., Marlin R; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Schlegl R; VALNEVA Austria GmbH, Vienna, Austria., Seidel S; VALNEVA Austria GmbH, Vienna, Austria., Bartuschka U; VALNEVA Austria GmbH, Vienna, Austria., Heindl-Wruss J; VALNEVA Austria GmbH, Vienna, Austria., Relouzat F; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Langlois S; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Dereuddre-Bosquet N; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Morin J; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Galpin-Lebreau M; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Gallouët AS; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Gros W; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Naninck T; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Pascal Q; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Chapon C; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Mouchain K; ONCODESIGN SERVICES, François Hyafil Research Center, Villebon-sur-Yvette, France., Fichet G; ONCODESIGN SERVICES, François Hyafil Research Center, Villebon-sur-Yvette, France., Lemaitre J; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Cavarelli M; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Contreras V; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France., Legrand N; ONCODESIGN SERVICES, François Hyafil Research Center, Villebon-sur-Yvette, France., Meinke A; VALNEVA Austria GmbH, Vienna, Austria. Andreas.MEINKE@valneva.com., Le Grand R; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France. roger.le-grand@cea.fr.
Source: Communications medicine [Commun Med (Lond)] 2024 Apr 03; Vol. 4 (1), pp. 62. Date of Electronic Publication: 2024 Apr 03.
Publication Type: Journal Article
Journal Info: Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918250414506676 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-664X (Electronic) Linking ISSN: 2730664X NLM ISO Abbreviation: Commun Med (Lond) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38570605
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immunogenicity and efficacy of VLA2001 vaccine against SARS-CoV-2 infection in male cynomolgus macaques.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Galhaut+M%22">Galhaut M</searchLink>; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.<br /><searchLink fieldCode="AU" term="%22Lundberg+U%22">Lundberg U</searchLink>; VALNEVA Austria GmbH, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Marlin+R%22">Marlin R</searchLink>; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.<br /><searchLink fieldCode="AU" term="%22Schlegl+R%22">Schlegl R</searchLink>; VALNEVA Austria GmbH, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Seidel+S%22">Seidel S</searchLink>; VALNEVA Austria GmbH, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Bartuschka+U%22">Bartuschka U</searchLink>; VALNEVA Austria GmbH, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Heindl-Wruss+J%22">Heindl-Wruss J</searchLink>; VALNEVA Austria GmbH, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Relouzat+F%22">Relouzat F</searchLink>; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.<br /><searchLink fieldCode="AU" term="%22Langlois+S%22">Langlois S</searchLink>; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.<br /><searchLink fieldCode="AU" term="%22Dereuddre-Bosquet+N%22">Dereuddre-Bosquet N</searchLink>; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.<br /><searchLink fieldCode="AU" term="%22Morin+J%22">Morin J</searchLink>; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.<br /><searchLink fieldCode="AU" term="%22Galpin-Lebreau+M%22">Galpin-Lebreau M</searchLink>; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.<br /><searchLink fieldCode="AU" term="%22Gallouët+AS%22">Gallouët AS</searchLink>; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.<br /><searchLink fieldCode="AU" term="%22Gros+W%22">Gros W</searchLink>; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.<br /><searchLink fieldCode="AU" term="%22Naninck+T%22">Naninck T</searchLink>; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.<br /><searchLink fieldCode="AU" term="%22Pascal+Q%22">Pascal Q</searchLink>; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.<br /><searchLink fieldCode="AU" term="%22Chapon+C%22">Chapon C</searchLink>; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.<br /><searchLink fieldCode="AU" term="%22Mouchain+K%22">Mouchain K</searchLink>; ONCODESIGN SERVICES, François Hyafil Research Center, Villebon-sur-Yvette, France.<br /><searchLink fieldCode="AU" term="%22Fichet+G%22">Fichet G</searchLink>; ONCODESIGN SERVICES, François Hyafil Research Center, Villebon-sur-Yvette, France.<br /><searchLink fieldCode="AU" term="%22Lemaitre+J%22">Lemaitre J</searchLink>; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.<br /><searchLink fieldCode="AU" term="%22Cavarelli+M%22">Cavarelli M</searchLink>; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.<br /><searchLink fieldCode="AU" term="%22Contreras+V%22">Contreras V</searchLink>; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France.<br /><searchLink fieldCode="AU" term="%22Legrand+N%22">Legrand N</searchLink>; ONCODESIGN SERVICES, François Hyafil Research Center, Villebon-sur-Yvette, France.<br /><searchLink fieldCode="AU" term="%22Meinke+A%22">Meinke A</searchLink>; VALNEVA Austria GmbH, Vienna, Austria. Andreas.MEINKE@valneva.com.<br /><searchLink fieldCode="AU" term="%22Le+Grand+R%22">Le Grand R</searchLink>; Center for Immunology of Viral, Auto-immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, Fontenay-aux-Roses, France. roger.le-grand@cea.fr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918250414506676%22">Communications medicine</searchLink> [Commun Med (Lond)] 2024 Apr 03; Vol. 4 (1), pp. 62. <i>Date of Electronic Publication: </i>2024 Apr 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Portfolio%22">Nature Portfolio </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9918250414506676 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2730-664X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222730664X%22">2730664X </searchLink><i>NLM ISO Abbreviation: </i>Commun Med (Lond) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38570605
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s43856-024-00488-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 62
    Titles:
      – TitleFull: Immunogenicity and efficacy of VLA2001 vaccine against SARS-CoV-2 infection in male cynomolgus macaques.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Galhaut M
      – PersonEntity:
          Name:
            NameFull: Lundberg U
      – PersonEntity:
          Name:
            NameFull: Marlin R
      – PersonEntity:
          Name:
            NameFull: Schlegl R
      – PersonEntity:
          Name:
            NameFull: Seidel S
      – PersonEntity:
          Name:
            NameFull: Bartuschka U
      – PersonEntity:
          Name:
            NameFull: Heindl-Wruss J
      – PersonEntity:
          Name:
            NameFull: Relouzat F
      – PersonEntity:
          Name:
            NameFull: Langlois S
      – PersonEntity:
          Name:
            NameFull: Dereuddre-Bosquet N
      – PersonEntity:
          Name:
            NameFull: Morin J
      – PersonEntity:
          Name:
            NameFull: Galpin-Lebreau M
      – PersonEntity:
          Name:
            NameFull: Gallouët AS
      – PersonEntity:
          Name:
            NameFull: Gros W
      – PersonEntity:
          Name:
            NameFull: Naninck T
      – PersonEntity:
          Name:
            NameFull: Pascal Q
      – PersonEntity:
          Name:
            NameFull: Chapon C
      – PersonEntity:
          Name:
            NameFull: Mouchain K
      – PersonEntity:
          Name:
            NameFull: Fichet G
      – PersonEntity:
          Name:
            NameFull: Lemaitre J
      – PersonEntity:
          Name:
            NameFull: Cavarelli M
      – PersonEntity:
          Name:
            NameFull: Contreras V
      – PersonEntity:
          Name:
            NameFull: Legrand N
      – PersonEntity:
          Name:
            NameFull: Meinke A
      – PersonEntity:
          Name:
            NameFull: Le Grand R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 04
              Text: 2024 Apr 03
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2730-664X
          Numbering:
            – Type: volume
              Value: 4
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Communications medicine
              Type: main
ResultId 1